Robinson Bradshaw

Topic: public genomics

Completing the Personal Genomics Toolkit

The big news buzzing through the world of genomics this afternoon is the publication of a paper in the journal Science announcing the production of three whole-genome sequences at an average materials cost of $4,400. The work was performed by the third-generation sequencing company Complete Genomics Incorporated, along with researchers from George Church’s lab at Harvard […]

Enabling Responsible Public Genomics

In the few short months since its launch, we’ve found the Genomics Law Report to be a flexible forum for discussing the legal implications of current developments in the fields of genomics and personalized medicine. Often what reaches the pages of the GLR, however, represents only the highlights from more detailed research and analysis that […]

Co-Founder Linda Avey Leaves 23andMe to Start New Alzheimer’s Foundation

DTC genomics company 23andMe announced late Friday afternoon that co-founder Linda Avey was leaving the personal genomics start-up, effective immediately, to begin work on a new foundation focusing on Alzheimer’s disease. Kara Swisher at BoomTown has the full scoop, including copies of internal emails to 23andMe employees from both Linda Avey and the company’s other co-founder, […]

Leveraging the Crowd to Understand Your Genome

Earlier this week Peter Aldhous of NewScientist magazine recounted an unusual experience with DTC genomics provider Decode Genetics. In reviewing his genetic data on the deCODEme website, Aldhous uncovered what appeared to be significant and bizarre errors in his mitochondrial DNA. Aldhous turned to Blaine Bettinger, The Genetic Genealogist, for help in diagnosing the problem […]

Crowd-Sourcing vs. Open-Sourcing in Consumer Genomics

The New York Times yesterday described the emerging phenomenon of utilizing patient and online communities to jumpstart scientific research. In a previous post (Genomic Research Goes DTC) I discussed this trend, as well as a number of the legal uncertainties surrounding this new research model, particularly in the case of genomic research conducted by private […]

Genomic Research Goes DTC

The first generation of Direct-to-Consumer genetic testing and sequencing was populated by companies such as 23andMe, Navigenics and deCODEme that offered genotyping for a limited set of conditions, focusing primarily on genealogy and monogenic traits. As the cost of generating genetic data continued to decline new companies brought new commercial offerings to the table, including […]